Taku Obara Selected Research

White Coat Hypertension

8/2013	The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan.
9/2010	Relationship of dysregulation of glucose metabolism with white-coat hypertension: the Ohasama study.
5/2009	Detection of silent cerebrovascular lesions in individuals with 'masked' and 'white-coat' hypertension by home blood pressure measurement: the Ohasama study.
2/2007	Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study.
8/2005	Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
7/2005	White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taku Obara Research Topics

Disease

32	Hypertension (High Blood Pressure) 02/2024 - 10/2004
9	Essential Hypertension 10/2021 - 10/2004
9	Stroke (Strokes) 08/2018 - 08/2005
9	Diabetes Mellitus 11/2017 - 04/2007
6	White Coat Hypertension 08/2013 - 07/2005
5	Neural Tube Defects (Exencephaly) 03/2022 - 03/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2015 - 04/2007
5	Masked Hypertension 08/2013 - 08/2005
4	Obesity 09/2021 - 09/2005
4	Heart Diseases (Heart Disease) 08/2015 - 09/2006
4	Hypercholesterolemia 12/2013 - 04/2007
3	Birth Weight (Birth Weights) 02/2024 - 01/2020
3	Drug-Related Side Effects and Adverse Reactions 01/2024 - 01/2021
3	Infections 01/2024 - 11/2017
2	Chronic Renal Insufficiency 04/2024 - 08/2012
2	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2024 - 01/2019
2	Dyslipidemias (Dyslipidemia) 02/2024 - 07/2022
2	Human Influenza (Influenza) 01/2024 - 01/2020
2	Neoplasms (Cancer) 12/2023 - 01/2023
2	Postpartum Depression (Post-Natal Depression) 08/2023 - 12/2022
2	Pre-Eclampsia (Preeclampsia) 01/2023 - 01/2021
2	Autism Spectrum Disorder 12/2022 - 10/2018
2	Type 2 Diabetes Mellitus (MODY) 10/2022 - 07/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 01/2018
2	Proteinuria 01/2022 - 08/2012
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2021 - 01/2020
2	Hyperaldosteronism (Conn Syndrome) 08/2012 - 03/2011
2	Cerebral Infarction 01/2012 - 02/2006
2	Hyperlipidemias (Hyperlipidemia) 09/2010 - 12/2008
2	Lacunar Stroke 05/2009 - 04/2007
1	Glioma (Gliomas) 03/2024
1	Weight Gain 02/2024
1	Premature Birth (Birth, Premature) 01/2024
1	Schizophrenia (Dementia Praecox) 01/2024
1	Death (Near-Death Experience) 01/2023
1	Constipation 01/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2022
1	Triple X syndrome 12/2022
1	Non-alcoholic Fatty Liver Disease 07/2022
1	Epilepsy (Aura) 05/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Fetal Death 01/2022
1	Mumps 11/2021

Drug/Important Bio-Agent (IBA)

27	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 10/2004
8	SodiumIBA 02/2024 - 03/2011
7	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022 - 03/2017
5	PotassiumIBA 02/2024 - 01/2014
5	SaltsIBA 02/2024 - 09/2010
5	ORALIT (ORS)IBA 01/2024 - 12/2019
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 06/2008
5	AldosteroneIBA 02/2015 - 03/2011
4	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2010
4	Indicators and Reagents (Reagents)IBA 02/2024 - 01/2020
4	Angiotensin Receptor AntagonistsIBA 07/2022 - 11/2012
4	ReninIBA 02/2015 - 03/2011
3	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 11/2016
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2013 - 11/2007
3	mahuang-tangIBA 05/2009 - 08/2005
2	TransferasesIBA 03/2024 - 02/2024
2	Oseltamivir (Tamiflu)FDA Link 01/2024 - 01/2021
2	Tuberculin (PPD)IBA 08/2023 - 12/2022
2	LipidsIBA 10/2022 - 07/2022
2	CalciumIBA 01/2022 - 09/2021
2	1,4-dihydropyridine (dihydropyridine)IBA 01/2022 - 01/2022
2	VaccinesIBA 11/2021 - 07/2020
2	DiureticsIBA 10/2021 - 11/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 08/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 08/2015
2	Dietary SodiumIBA 02/2015 - 03/2011
1	MethyltransferasesIBA 03/2024
1	FumaratesIBA 02/2024
1	tenofovir alafenamideIBA 02/2024
1	oxidized low density lipoproteinIBA 02/2024
1	Aripiprazole (Abilify)FDA Link 01/2024
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2024
1	Pemetrexed (MTA)FDA Link 12/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2023
1	CytokinesIBA 08/2023
1	Magnesium Oxide (Magnesia)FDA Link 01/2023
1	Dietary CalciumIBA 01/2023
1	Fluconazole (Zonal)FDA LinkGeneric 09/2022
1	rilmazafoneIBA 09/2022
1	Itraconazole (Sporanox)FDA LinkGeneric 09/2022
1	ThiazolidinesIBA 07/2022
1	Fibric Acids (Fibrates)IBA 07/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 05/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 05/2022
1	FatsIBA 09/2021
1	Zanamivir (Relenza)FDA Link 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Amantadine (Aman)FDA LinkGeneric 01/2021

Therapy/Procedure

4	Drug Prescriptions 01/2024 - 01/2020
4	Therapeutics 01/2023 - 01/2011
1	Drug Therapy (Chemotherapy) 01/2023
1	Terminal Care (Care, Terminal) 01/2023
1	Kampo Medicine (Kampo) 01/2023
1	Cesarean Section (Caesarean Section) 01/2022
1	Perinatal Care 01/2021